Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2014.546 | Intravenous thrombolysis with or without early aspiration thrombectomy for acute anterior stroke with large thrombus burden -The INSTANT trial | Professor Yu Chun Ho |
| 2019.261 | Percutaneous Lung Biopsy using Cone Beam CT with Virtual Guidance: a randomized control trial | Prof. YU Chun Ho |
| 2008.211 | Endovascular Treatment of Adenomyosis with Transarterial Embolization with Lipiodol-Ethanol Mixture (LEM) | Dr Yu Chun Ho, Simon |
| 2019.717 | Exploring the level of physical activity for people diagnosed with severe mental illness in psychiatric day hospital (PDH) of Hong Kong and the relationship of physical activity and self-efficacy. |
Mr. YU Chun Lok 余俊樂 |
| 2012.463 | Effectiveness of a parent-targeted plant-based cooking and education programme on dietary pattern and cardiovascular health in overweight children | Dr Yu Chung wah Clare |
| 2019.046 | Frailty screening in elderly patients before and after hospitalization |
Prof. YU Doris Sau Fung 余秀鳳 |
| 2019.047 | New wine in old bottle: the effects of SUDOKU Mind Activation and Revitalizing Training (SMART) Program on cognitive function among people with mild cognitive impairment | Prof. YU Doris Sau Fung |
| 2017.272 | The effects and cost-effectiveness of a nurse-coordinated integrated heart failure- palliative care (NCI-HF-PC) model for patients with advanced heart failure: a randomised controlled trial |
Prof. YU Doris Sau Fung 余秀鳳 |
| 2015.168 | The effects of Chair‐based dance exercise on physical, cognitive and psychological health among community‐dwelling older adults who reported fatigue |
Prof. YU Doris Sau Fung 余秀鳳 |
| 2015.516 | Enhancing the self-care of Chinese patients with chronic heart failure: Does an empowerment-based educational model make a difference? | Prof. YU Doris Sau Fung |
| 2017.090 | Unravelling positive aspect of caregiving in dementia: an integration of the Transactional Stress and Coping Model and Meaning Making Model | Prof. YU Doris Sau Fung |
| 2016.063 | The effects of a strengths–based intervention based on salutogenic model on sense of coherence, coping, psychological status and health-related quality of life of family caregivers of persons with dementia | Prof. YU Doris Sau Fung |
| 2017.380 | The effects of strengths-based dyadic program on health-related quality of life (HRQL) of people with mild cognitive impairment and mild dementia in the community | Prof. YU Doris Sau Fung |
| 2014.003 | A Nurse-led End-of-life (EOL) Program for frail elders with end stage chronic diseases | Prof. YU Doris Sau Fung |
| 2019.097 | Using a vulnerability-stress model to predict expressed emotion among family caregivers of persons with dementia: A sequential explanatory mixed-method study | Prof. YU Doris Sau-Fung |
| 2010.606 | What determine influenza vacination in community-dwelling older people with medical risk factors for influenza-related complication | Prof Yu Doris, Sau-fung |
| 2021.383 | Creating a healthy longevity index and developing a holistic model of how personal and environmental factors affect this index | Dr. YU Ho Yan |
| 2021.431 | Towards healthy ageing: Measurement of intrinsic capacity and its associated factors and health outcomes in community-dwelling older people | Dr. YU Ho Yan |
| 2020.583 | Use of technology to prevent and manage frailty and promote healthy ageing in Hong Kong | Dr. YU Ho Yan |
| 2022.322 | The effectiveness of patient navigator intervention in promoting the uptake of colorectal cancer screening for the average risk older adults in Hong Kong: A pilot study |
Ms. YU Hoi Un 余海鶯 |
| 2013.481 | Pilot study on the effect of hearing aid use on the change of cognitive function on elderly with hearing impairment | Dr. Yu Joannie Ka Yin |
| 2008.146 | Association of NF-kappaB Super Suppressor (NEKBIA) Polymorphism with Gastric Cancer Risk: A Case-control Study | Dr YU Jun |
| 2012.123 | The genome-wide characterization of the molecular mechanisms in Epstein-Barr Virus-associated gastric cancer using next-generation sequencing technology | Dr YU JUN |
| 2011.143 | Functional significance and clinical aplication of Epstein-Barr Virus-driven novel promoter hypermethylated genes (SSTR1, REC8, IL15RA) in gastric cancer | Dr YU JUN |
| 2013.263 | Elucidating dysbiotic gut microbiota associated with colorectal cancer by metagenomic sequencing | Dr YU JUN |
| 2013.436 | Pathogenesis of non-alcoholic fatty liver disease: molecular basis and clinical application | Prof YU JUN |
| 2012.283 | Functional characterization and clinical implication of AMPD1, a novel recurrent mutation gene identified by whole exome sequencing in colon cancer | Dr YU JUN |
| 2013.149 | Genome-wide Identification and Characterization of Genomic Mutations in Non-alcoholic Steatohepatitis-induced Hepatocellular Carcinoma | Dr. YU Jun |
| 2008.182 | Latent-lytic Switch of Epstein-Barr Virus Infection in EBV Associated Gastric Cancer | Dr YU Jun |
| 2013.364 | Functional characterization and clinical implication of SLC12A5, a novel early mutated gene identified by single cell sequencing in colon cancer | Dr. YU Jun |
| 2022.203 | Altered gut microbiome composition by appendectomy contributes to colorectal cancer |
Prof. YU Jun 于君 |
| 2023.114 | RNA m6A去甲基化酶ALKBH5对结直肠癌化疗疗效的影响及作用机制 (Targeting RNA m6A eraser ALKBH5 boosts the efficacy of chemotherapy in colorectal cancer) |
Prof. YU Jun 于君 |
| 2023.631 | Targeting Cancer Stem Cells in Non-alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications |
Prof. YU Jun 于君 |
| 2023.022 | RNA N6-Methyladenosine Demethylase AlkB Homolog 5 (ALKBH5) promotes stemness and chemoresistance in colorectal cancer: mechanism and novel therapeutic approaches |
Prof. YU Jun 于君 |
| 2023.016 | Microbiota in Gastrointestinal Cancers: Mechanistic Investigation and Clinical Applications |
Prof. YU Jun 于君 |
| 2023.017 | Deciphering the role of gut microbiota in modulating antitumor immune response in colorectal cancer: mechanisms and translational value |
Prof. YU Jun 于君 |
| 2021.451 | Developing probiotics into high-efficacy and safe prophylactics and adjuvant therapies for colorectal cancer |
Prof. YU Jun 于君 |
| 2023.457 | Targeting m6A modification to boost chemotherapy and immunotherapy efficacy in colorectal cancer |
Prof. YU Jun 于君 |
| 2022.108 | RNA m6A甲基化识别蛋白YTHDF1在调控结直肠癌免疫微环境中的作用及机制研究 (Elucidating the role and mechanism of RNA m6A reader YTHDF1 in regulating the immune microenvironment of colorectal cancer) |
Prof. YU Jun 于君 |
| 2022.025 | Modulation of antitumor immune response by gut microbiota: characterization, molecular mechanism and translational value |
Prof. YU Jun 于君 |
| 2022.026 | RNA N6-Methyladenosine (m6A) Methyltransferase METTL3 facilitates non-alcoholic fatty liver disease-associated hepatocellular carcinoma (NAFLDHCC) via a m6A-cholesterol axis to repress T-cell function |
Prof. YU Jun 于君 |
| 2020.684 | RNA Demethylase AlkB Homolog 5 (ALKBH5) drives immune suppression in colorectal cancer via epitranscriptome regulation of AXIN2-WNT-DKK1 axis |
Prof. YU Jun 于君 |
| 2020.685 | Deciphering the role and molecular mechanisms of predominant bacterial pathogens in colorectal cancer pathogenesis and augment therapies |
Prof. YU Jun 于君 |
| 2008.531 | Clarification of the role of H. pylori infection on the activation of STAT3 through dissecting STAT3 signaling network in gastric cancer | Dr YU Jun |
| 2008.536 | Epstein-Barr Virus and Gastric Cancer: Viral Carcinogenesis through DNA Methylation | Dr YU Jun |
| 2024.570 | Faecalibacterium prausnitzii potentiates chemotherapy response in colorectal cancer: molecular mechanisms and translational implications | Prof. YU Jun |
| 2019.132 | A study of the clinical significance and molecular mechanism of TRIP6 in colorectal cancer invasion and metastasis. |
Prof. YU Jun 于君 |
| 2018.359 | Centre for Gut Microbiome in Cancers |
Prof. YU Jun 于君 |
| 2019.425 | Exploiting epitranscriptome dysregulation in colorectal carcinogenesis and metastasis: mechanisms and novel therapeutic approaches |
Prof. YU Jun 于君 |
| 2018.463 | Gut microbiota and Hepatocellular carcinoma | Prof. YU Jun |
Page 258 of 265.